These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 26609768)

  • 1. Spherulites: onion-like vesicles as nanomedicines.
    Crauste-Manciet S; Khawand K; Mignet N
    Ther Deliv; 2015; 6(12):1377-85. PubMed ID: 26609768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipidic spherulites: formulation optimisation by paired optical and cryoelectron microscopy.
    Crauste-Manciet S; Larquet E; Khawand K; Bessodes M; Chabot GG; Brossard D; Mignet N
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1088-94. PubMed ID: 23523544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polysaccharide-based nucleic acid nanoformulations.
    Raemdonck K; Martens TF; Braeckmans K; Demeester J; De Smedt SC
    Adv Drug Deliv Rev; 2013 Aug; 65(9):1123-47. PubMed ID: 23680381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complex dispersions of multilamellar vesicles: a promising new carrier for controlled release and protection of encapsulated molecules.
    Genty M; Couarraze G; Laversanne R; Degert C; Maccario J; Grossiord JL
    J Control Release; 2003 Jun; 90(1):119-33. PubMed ID: 12767712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of sterilizing-grade filters on the physico-chemical properties of onion-like vesicles.
    Richard A; Delvaux J; Bourel-Bonnet L
    Int J Pharm; 2006 Apr; 312(1-2):144-50. PubMed ID: 16480839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug delivery of oligonucleotides by peptides.
    Lochmann D; Jauk E; Zimmer A
    Eur J Pharm Biopharm; 2004 Sep; 58(2):237-51. PubMed ID: 15296952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide-Assisted Nucleic Acid Delivery Systems on the Rise.
    Tarvirdipour S; Skowicki M; Schoenenberger CA; Palivan CG
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of nanoparticles for therapeutics.
    Hall JB; Dobrovolskaia MA; Patri AK; McNeil SE
    Nanomedicine (Lond); 2007 Dec; 2(6):789-803. PubMed ID: 18095846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesoporous silica nanoparticles as nanocarriers.
    Wu SH; Hung Y; Mou CY
    Chem Commun (Camb); 2011 Sep; 47(36):9972-85. PubMed ID: 21716992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of peptide and protein nanotherapeutics by nanoencapsulation and nanobioconjugation.
    Yadav SC; Kumari A; Yadav R
    Peptides; 2011 Jan; 32(1):173-87. PubMed ID: 20934475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesoporous Silica Nanoparticles Decorated with Carbosilane Dendrons as New Non-viral Oligonucleotide Delivery Carriers.
    Martínez Á; Fuentes-Paniagua E; Baeza A; Sánchez-Nieves J; Cicuéndez M; Gómez R; de la Mata FJ; González B; Vallet-Regí M
    Chemistry; 2015 Oct; 21(44):15651-66. PubMed ID: 26361378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acid-induced release of curcumin from calcium containing nanotheranostic excipient.
    Wang A; Muhammad F; Qi W; Wang N; Chen L; Zhu G
    ACS Appl Mater Interfaces; 2014 Aug; 6(16):14377-83. PubMed ID: 25025519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges in design of translational nanocarriers.
    Sun Q; Radosz M; Shen Y
    J Control Release; 2012 Dec; 164(2):156-69. PubMed ID: 22664472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and in vitro evaluation of lipidic carriers and fillers for inhalation.
    Sebti T; Amighi K
    Eur J Pharm Biopharm; 2006 May; 63(1):51-8. PubMed ID: 16380243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single step bottom-up process to generate solid phospholipid nano-particles.
    Brinkmann-Trettenes U; Barnert S; Bauer-Brandl A
    Pharm Dev Technol; 2014 May; 19(3):326-32. PubMed ID: 23528006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent Developments in the Application of Polymeric Nanoparticles as Drug Carriers.
    Moritz M; Geszke-Moritz M
    Adv Clin Exp Med; 2015; 24(5):749-58. PubMed ID: 26768624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multifunctional Cargo-Free Nanomedicine for Cancer Therapy.
    Wang Y; Yang P; Zhao X; Gao D; Sun N; Tian Z; Ma T; Yang Z
    Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30274177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing synthetic nucleic acid and protein nanocarriers: The chemical evolution approach.
    Freitag F; Wagner E
    Adv Drug Deliv Rev; 2021 Jan; 168():30-54. PubMed ID: 32246984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbon nanotubes as functional excipients for nanomedicines: II. Drug delivery and biocompatibility issues.
    Foldvari M; Bagonluri M
    Nanomedicine; 2008 Sep; 4(3):183-200. PubMed ID: 18550450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.